Interestingly, neutralization of CD8 and CD4 T cells reversed the tumor control and survival advantage achieved with combination therapy, suggesting the shift in the CD8:Treg ratio was biologically important (Figure 5F, Supplemental Figure S14C, D, http://links.lww.com/HC9/A993). This evidence concerns the gene CD8A and neoplasm.